Hiring outlook, remote working rates, and which companies are actively recruiting.
Bioinformatics and pharma tech data engineering hiring in Switzerland has accelerated through 2025 into 2026 as Roche and Novartis expand AI-driven drug discovery programmes out of Basel, and the wider Basel biotech cluster scales up its own data infrastructure to match. Roche and Novartis are the dominant hirers, and Switzerland's non-EU work-permit quota system means specialist candidates from outside the EU/EFTA area can face longer approval timelines even as demand for their skills stays strong.
of Switzerland Bioinformatics / Pharma-Tech Data Engineer roles advertise remote or hybrid working
Year-on-year salary movement in Switzerland. Positive movement signals active market competition.
Strongest in: Basel's concentration of global pharma R&D at Roche and Novartis, alongside a dense cluster of biotech firms around the Basel life-sciences campus, drives most of the demand for engineers who can bridge lab science and production data infrastructure.
Bioinformatics and pharma tech data engineering hiring in Switzerland has accelerated through 2025 into 2026 as Roche and Novartis expand AI-driven drug discovery programmes out of Basel, and the wider Basel biotech cluster scales up its own data infrastructure to match. Roche and Novartis are the dominant hirers, and Switzerland's non-EU work-permit quota system means specialist candidates from outside the EU/EFTA area can face longer approval timelines even as demand for their skills stays strong.
Salary premium over the Switzerland median for Bioinformatics / Pharma-Tech Data Engineers who list these skills.
Companies with consistent or active Bioinformatics / Pharma-Tech Data Engineer hiring in Switzerland.
Monthly briefing
Get our monthly salary and market update
Salary movements, contractor rate changes, tax updates, and new tools. Sent once a month, no noise.
No spam. Unsubscribe any time. GDPR-compliant.
Demand is very high and still growing. Roche and Novartis have both expanded AI-driven drug discovery investment out of Basel through 2025 into 2026, and the smaller biotech firms clustered around the Basel life-sciences campus are competing for the same limited pool of engineers who can handle both software engineering and genomic data.
Roche and Novartis are the largest and most consistent hirers, both headquartered in Basel. Lonza, Idorsia, and Bachem also run active bioinformatics data teams, and the SIB Swiss Institute of Bioinformatics is a steady source of research-adjacent roles.